AMEVIVE® Pregnancy Registry

TerminatedOBSERVATIONAL
Enrollment

3

Participants

Timeline

Start Date

December 31, 2003

Primary Completion Date

December 31, 2011

Study Completion Date

December 31, 2011

Conditions
Pregnancy
Interventions
DRUG

Amevive exposure

Observational

Trial Locations (1)

28405

INC Research, Wilmington

Sponsors
All Listed Sponsors
lead

Astellas Pharma Inc

INDUSTRY

NCT00342862 - AMEVIVE® Pregnancy Registry | Biotech Hunter | Biotech Hunter